WALTHAM, Mass., Jan. 19, 2026 (GLOBE NEWSWIRE) -- BVI, a global leader in the ophthalmic device market, announced today the appointment of Jim Hollingshead as President & Chief Executive Officer.

Reference is made to the stock exchange release published by Hexagon Purus (the “Company”) on 16 June 2025, in which the ...

Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.

WALTHAM, Mass.--(BUSINESS WIRE)--BVI Medical, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the completion of a $1 ...

The British Virgin Islands (BVI) play a key role in facilitating international business. Its strong reputation and strict adherence to international standards position the territory as the trusted ...